Evidence map›Paper›PMID 40798990›Full record

ArticleACS biomaterials science & engineering2025

Engineered Extraocular Muscle with Decellularized Tissue and Synthetic Biodegradable Polymers: Design, Properties, and

Fatma Yülek, Özge Ekin Akdere, Sena Koç Akbayrak, Menemşe Gümüşderelioğlu, Sevil Çaylı, Ebru Alimoğulları, Ayşen Erdem, Meltem Tuncer, Özbeyen Atalay

Abstract read
In one paragraph

Article in ACS biomaterials science & engineering, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Fatma YülekDepartment of Ophthalmology, Yıldırım Beyazıt University Faculty of Medicine, Ankara 06031, Turkey.
Özge Ekin AkdereDepartment of Bioengineering, Hacettepe University, Ankara 06800, Turkey.
Sena Koç AkbayrakDepartment of Chemical Engineering, Hacettepe University, Ankara 06800, Turkey.ORCID 0000-0001-8329-980X
Menemşe GümüşderelioğluDepartment of Bioengineering, Hacettepe University, Ankara 06800, Turkey.ORCID 0000-0003-1256-0972
Sevil ÇaylıDepartment of Histology, Yıldırım Beyazıt University Faculty of Medicine, Ankara 06031, Turkey.
Ebru AlimoğullarıDepartment of Histology, Yıldırım Beyazıt University Faculty of Medicine, Ankara 06031, Turkey.
Ayşen ErdemDepartment of Physiology, Faculty of Medicine, Hacettepe University, Ankara 06230, Turkey.
Meltem TuncerDepartment of Physiology, Faculty of Medicine, Hacettepe University, Ankara 06230, Turkey.
Özbeyen AtalayDepartment of Physiology, Faculty of Medicine, Hacettepe University, Ankara 06230, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The study aims to develop graft materials suitable for treating severe muscle loss and thyroid ophthalmopathy. A new hybrid graft combining poly(caprolactone) (PCL), poly(lactic-

Indexed as

Biocompatible MaterialsOculomotor MusclesPolyestersTissue EngineeringTissue ScaffoldsAnimalsCattleCell AdhesionCell LineCell ProliferationLactic AcidMiceMyoblastsPolyglycolic AcidPolylactic Acid-Polyglycolic Acid CopolymerRabbitsBiocompatible MaterialsLactic AcidpolycaprolactonePolyestersPolyglycolic AcidPolylactic Acid-Polyglycolic Acid Copolymerdecellularizationelectrospinningextraocular muscleextraocular muscle regenerationpoly(caprolactone) (PCL)poly(lactic-co-glycolic acid) (PLGA)

Identifiers

PMID40798990
PMCPMC12421506

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.